CN107236686A - A kind of dactylosporangium aurantiacum and its application in regulating microorganism metabolism thing feldamycin - Google Patents

A kind of dactylosporangium aurantiacum and its application in regulating microorganism metabolism thing feldamycin Download PDF

Info

Publication number
CN107236686A
CN107236686A CN201710473850.7A CN201710473850A CN107236686A CN 107236686 A CN107236686 A CN 107236686A CN 201710473850 A CN201710473850 A CN 201710473850A CN 107236686 A CN107236686 A CN 107236686A
Authority
CN
China
Prior art keywords
culture
medium
seed
fermentation
culture medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201710473850.7A
Other languages
Chinese (zh)
Other versions
CN107236686B (en
Inventor
陈晓霞
王蓓
赵万忠
冯国栋
谢海军
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hangzhou Huadong Medicine Group Biopharmaceutical Co ltd
Original Assignee
Hangzhou Huadong Medicine Group Biopharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hangzhou Huadong Medicine Group Biopharmaceutical Co ltd filed Critical Hangzhou Huadong Medicine Group Biopharmaceutical Co ltd
Priority to CN201710473850.7A priority Critical patent/CN107236686B/en
Publication of CN107236686A publication Critical patent/CN107236686A/en
Application granted granted Critical
Publication of CN107236686B publication Critical patent/CN107236686B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention discloses a kind of dactylosporangium aurantiacum (Dactylosporangium aurantiacum) FID1307 and its application, the strain is by China typical culture collection center preservation, and preserving number is CCTCC NO:M2017311, preservation date is:On 06 07th, 2017.The invention also discloses a kind of method that thus strain fermentation prepares feldamycin.The zymotechnique that the present invention is provided is through big production practices, it was demonstrated that its fermentation stability, accessory substance are few, the difficulty extracted after greatly reducing, suitable industrialized production, and the feldamycin product quality obtained is high.

Description

A kind of dactylosporangium aurantiacum and its in regulating microorganism metabolism thing feldamycin Using
Technical field
Applied the present invention relates to a kind of microorganism and its in pharmaceutical field, specifically dactylosporangium aurantiacum is by adjusting Control the application that microbial metabolism obtains feldamycin.
Background technology
Feldamycin (fidaxomicin, trade name Dificid, former name OPT-80, PAR-101), is to have 18 yuan of rings The macrolide antibiotics of structure, can be by dactylosporangium aurantiacum hamdenensis subspecies (Dactylosporangium Aurantiacumsubspecie hamdenensis) ferment and obtain, it can specifically refer to sporangiocyst bacterium NRRL 18085 by actinomyces and produce It is raw.The obtained product of dactylosporangium aurantiacum fermentation is family and feldamycin structure very close product, and referred to as platform hooks mycin (tiacumicins) it is, different by structure, it is referred to as Tiacumicins A, B, C, D, E and F.Feldamycin hooks mould for the platform of R configurations Plain B, with new mechanism of action (structural formula is as follows).
Feldamycin obtains U.S. FDA approval listing in May, 2011, and for treating clostridium difficile, (difficulty distinguishes fusiform gemma bar Bacterium, Clostridium difficile) infection induced diarrhea (CDAD).This is the first treatment that FDA ratifies over nearly 30 years CDAD medicine, European Union's in December, 2011 approval listing.
(the denomination of invention of Chinese patent literature 03818016.2:Platform hooks the preparation of mycin) disclose and prepare TCM B Method, it is prepared to obtain in tunning, contain higher accessory substance, impurity (see accompanying drawing 1).
(the denomination of invention of Chinese patent literature 201310208223.2:A kind of Actinoplanes bacteria strain and its preparing non-reach Application in mycin) disclose and shown in its HPLC analysis chart (see accompanying drawing 2) for preparing tunning, figure in tunning Contain more accessory substance and impurity.
Those of ordinary skill in the art are known in the feldamycin tunning that prior art is prepared into containing more Debris, accessory substance, the presence of these materials will bring very big difficulty to follow-up purification, for some purification link in very The impurity that hardly possible is removed, will have a strong impact on the quality of final medicine.
The content of the invention
Regarding the issue above, the present invention provides the few feldamycin producing strains of a kind of fermentation stability, accessory substance, Application of the bacterial strain in feldamycin is prepared, and specific fermentation preparation are provided simultaneously.
The purpose of the present invention is realized by following technical proposal:
A kind of dactylosporangium aurantiacum, Classification And Nomenclature is Dactylosporangium aurantiacum FID1307, in State's Type Tissue Collection preservation (abbreviation CCTCC), preserving number is:CCTCC NO:M 2017311, preservation date is: On June 7th, 2017.
Described preserving number is CCTCC NO:The colony characteristicses of M 2017311 bacterial strain:Bacterium colony subcircular, surfacing, 1~2mm of colony diameter, median rise, no secretion and soluble pigment are produced.
Described preserving number is CCTCC NO:The bacterial strains of M 2017311 can be applied to fermentation and prepare feldamycin.The preparation side Method comprises the following steps:
A. bacterial strain uses deposit number for CCTCC NO:M 2017311 bacterial strain;
B. by the 30% glycerine mycelia cryovial prepared according to a conventional method, by the 3~5% of shake-flask seed culture medium volume Inoculum concentration accesses shake-flask seed culture medium, and 220~260rpm cultivates 2~3 days, obtains shake-flask seed liquid;
The inoculum concentration that shake-flask seed liquid is accumulated into 0.1~0.2% by seed tank culture matrix is inoculated in seeding tank, 120~ 200rpm, cultivates 3~4 days, obtains tank seed liquor;
Tank seed liquor is inoculated in fermentation tank culture medium by the inoculum concentration of fermentation tank culture medium volume 5~15%, 150~ 200rpm, fermented and cultured 9~12 days collects the resin in zymotic fluid;
Wherein cultivation temperature is 26~30 DEG C.
The ratio of wherein described shake-flask seed culture medium each component in the medium is:In every 100mL culture mediums, carbon source 1~4.5g, 4~7.7g of nitrogen source, 0.1~0.4g of inorganic salts, remaining is water;
The ratio of seed tank culture base each component in the medium is:In every 100mL culture mediums, 1.5~6g of carbon source, nitrogen source 5~9g, 0.2~0.6g of inorganic salts, remaining is water;
The ratio of fermentation tank culture medium each component in the medium is:In every 100mL culture mediums, 4.5~10g of carbon source, nitrogen 1.7~5g of source, 0.8~1.8g of inorganic salts, 3~6g of resin, remaining is water;
Wherein described culture medium each component ratio in the medium, shake-flask seed culture medium is preferably in a proportion of:Per 100mL In culture medium, 2~3g of carbon source, 5~7g of nitrogen source, 0.2~0.3g of inorganic salts, remaining is water;
Seed tank culture base each component being preferably in a proportion of in the medium:In every 100mL culture mediums, 2~4g of carbon source, nitrogen 6~8g of source, 0.3~0.5g of inorganic salts, remaining is water;
Fermentation tank culture medium each component being preferably in a proportion of in the medium:In every 100mL culture mediums, 5~8g of carbon source, nitrogen 2~4g of source, 0.8~1.2g of inorganic salts, 4~5g of resin, remaining is water.
Wherein described carbon source is selected from sucrose, glucose, oatmeal, D- xyloses, D-ribose, galactolipin, maltose, malt One or more in dextrin, cornstarch, soluble starch, farina, corn dextrin, glycerine;Nitrogen source is selected from sour water Solve casein, beef extract, yeast extract, yeast extract powder, malt and leach powder, dusty yeast, soy peptone, peptone, seitan One or more in powder, cotton seed meal, soybean cake powder, corn starch, corn protein powder, urea;Inorganic salts be selected from citrate, Potassium nitrate, CaCO3、K2HPO4、MnSO4.7H2O、NaCl、MgSO4.7H2O、FeSO4.7H2O、KH2PO4In one or more;Tree Fat is selected from any of HZ818, PAD900, HB60.
Wherein described culture medium is preferably:Carbon source is the one or more in glucose, cornstarch;Nitrogen source is beef Medicinal extract, dusty yeast, soybean cake powder, soy peptone, corn protein powder, the one or more of cotton seed meal;Inorganic salts are K2HPO4、 KH2PO4、CaCO3One or more;Resin is HZ818 or PAD900.
Preserving number of the present invention is CCTCC NO:M 2017311 bacterial strain is presently available for large-scale production Bacterial strain.Fermentation process is the important step of feldamycin production, and its fermentation level is directly related with technique quality, and the present invention is provided Zymotechnique by shake flask fermentation and the experiment of 10 tons of fermentation tanks, its stable production capacity.After testing, the bacterium provided with the present invention Strain and fermented and cultured can obtain the higher feldamycin of fermentation titer, while fermentation byproduct is less, product component is single, homology Thing miscellaneous peak is less, is detected through HPLC, feldamycin normalization content 40~43%.So as to be provided for follow-up industrialized production Good basis, reduces the difficulty of subsequent extracted, so as to be conducive to the acquisition of the feldamycin of high-quality, in industrialized production Application aspect there is very big advantage.
The zymotic fluid that the zymotic fluid prepared with the strain of the present invention is reported with Chinese patent literature is contrasted through HPLC, very Substantially the zymotic fluid impurity of the present invention is few, and concentration of active substance is higher, is conducive to big production.
Bacterial strain preservation situation:Wuhan China typical culture collection center (abbreviation CCTCC) is preserved in, deposit number is CCTCC NO:M 2017311.Preservation date is on June 7th, 2017.
Brief description of the drawings
Fig. 1 is the zymotic fluid HPLC figures in Chinese patent literature 03818016.2
Fig. 2 is the zymotic fluid HPLC figures in Chinese patent literature 201310208223.2
Fig. 3 schemes for the zymotic fluid HPLC of the embodiment of the present invention 2
Fig. 4 schemes for the zymotic fluid HPLC of the embodiment of the present invention 3
Fig. 5 schemes for the zymotic fluid HPLC of the embodiment of the present invention 4
Fig. 6 schemes for the zymotic fluid HPLC of the embodiment of the present invention 5
Embodiment
It is further described with reference to specific embodiment for the present invention, but can not be by method involved in scheme And technical parameter is interpreted as limitation of the present invention.
Embodiment 1:Preserving number is CCTCC NO:The culture of the bacterial strains of M 2017311 and physiological and biochemical property and utilization of carbon source Situation
1st, preserving number is CCTCC NO:The morphological feature of the strain culturings of M 2017311
It is CCTCC NO by preserving number:The inoculations of M 2017311 are in ISP2 (yeast extract malt leaches powder agar) culture Base, 30 DEG C are cultivated 10~14 days, are observed the morphological feature of bacterium colony and are described.
Observation finds that the colony growth enriches, 14 days 1~2mm of diameter;Cultivate early stage bacterium colony subcircular, late stage of culture edge Irregular projection, central concave;Mycelia orange of light color is to rose pink, and no secretion and soluble pigment are produced.
2nd, preserving number is CCTCC NO:The bacterial strain Physiology and biochemistry cultural characteristics of M 2017311
The cultural characteristic row of bacterial strain in the medium see the table below shown in 1.
The CCTCC NO of table 1:The strain culturing features of M 2017311
Culture medium Growing state Lawn color Soluble pigment
Isp2 yeast extracts malt leaches powder agar medium +++ Shallow orange -
Isp3 oatmeal agar ++ It is pale pinkish grey -
Isp4 inorganic salts-starch agar ++ It is shallow pale pinkish grey -
Isp5 glycerine asparagine agar +- It is shallow pale pinkish grey -
ISP6 peptones yeast extract soaks juice iron agar ++ It is light yellow -
ISP7 tyrosine agars +- It is shallow pale pinkish grey -
+:Growth is general;++:Growth is medium;+++:Growth is abundant;—:Lack
Base silk is few in ISP2 culture mediums, short, irregular branch, no gas silk, is formed on the surface of some agar mediums Dactylosporangium.
This time experiment culture medium based on peptone-phosphate, 30 DEG C of cultures, are periodically observed.As a result such as table 2 below Shown, result of the test is shown, the bacterial strain can assimilate sucrose, glucose, maltose, D- xyloses, glycerine, galactolipin, D-ribose etc., D-R, mannose, rhamnose, D-Fructose, lactose, sorbose etc. can not be utilized.
The CCTCC NO of table 2:M 2017311 utilization of carbon source situation
Carbon source Growing state
Sucrose +
Glucose +
Maltose +
D- xyloses +
Glycerine +
Galactolipin +
D-ribose +
Inositol ±
Raffinose ±
D-R -
Rhamnose -
Mannose -
D-Fructose -
Lactose -
Sorbose -
+:Sun is utilized;-:The moon is not utilized;±:Weakly positive is uncertain
Embodiment 2:Fermented and cultured prepares feldamycin
Preserving number is used for CCTCC NO:M 2017311 bacterial strain.
1st, Spawn incubation and preservation
Solid medium:Glucose 1g, soluble starch 2g, yeast extract powder 1g, acid hydrolyzed casein 0.5g, agar 2g, adds water to 100mL, pH and adjusts 7.0.
Solid culture method:Inoculation is in culture medium slant, and 30 DEG C are cultivated 8~10 days.
After solid culture terminates, it is standby that 4~10 DEG C of refrigerations are placed on inclined-plane.
2nd, shake-flask seed culture
Culture medium:Glucose 1g, cornstarch 0.5g, farina 0.5g, dusty yeast 1g, soy peptone 1.5g, Beef extract 2g, soybean cake powder 0.5g, CaCO30.4g, adds water to 100mL, pH7.0.
Liquid amount:100mL culture mediums, 121 DEG C of sterilizing 30min are filled in 500mL triangular flasks.
Inoculum concentration:5% (V/V) 30% glycerine mycelia cryovial
Cultivation temperature:30℃
Incubation time:3 days
Shaking speed:260rpm
Shake-flask seed cultural method:After 30% glycerine mycelia cryovial is thawed shaking flask kind is connect according to inoculum concentration 5% (V/V) In sub- culture medium, treat that mycelia length rises, have obvious wall built-up phenomenon and bacterium it is dense be more than 12%, by 1L shake-flask seed nutrient solutions, access In 1000L seeding tanks.
The making of 30% glycerine mycelia cryovial:Under aseptic conditions, the about 30mL of the glycerine after sterilizing is added and grown Kind bottle in, shake up and about 30% glycerine hyphal suspension be made, then dispense into small test tube (5mL/ branch), place it is -20 DEG C low Temperature refrigerator refrigeration is standby.
3rd, seeding tank seed culture medium
Seeding tank seed culture medium ratio and shake-flask seed culture medium ratio are consistent, add water to 500L, and pH adjusts 7.0.
Loading amount:1000L seeding tanks built-in culture medium 500L, 121 DEG C of sterilizing 30min.
Seed tank culture method:In cultured 1L shake-flask seed liquids access seeding tank, 30 DEG C, 4 days.Controlled in incubation Tank pressure processed:0.04MPa, mixing speed 120rpm, throughput 1:1(V/V).
After culture, microscopy mycelia is sturdy, and dyeing is deep, no microbiological contamination, and bacterium is dense >=and 12%.
4th, fermentation tank culture
The ratio of fermentation medium each component in the medium is:1g containing glucose, maltose in per 100mL culture mediums 5g, cornstarch 4g, soybean cake powder 1.5g, yeast extract 2g, soy peptone 1.5g, potassium nitrate 0.5g, NaCl 0.1g, CaCO3 0.2g, HZ818 6g, bubble enemy 0.15%, remaining is water, pH7.0.
Loading amount:6 tons of the built-in culture medium of 10 tons of fermentation tanks
Fermentation tank culture method:On cultured 500L tanks in seed liquor access fermentation tank, 30 DEG C, 12 days.Incubation Middle control tank pressure:0.04MPa, mixing speed 160rpm, throughput 1:1.3(V/V).
Fermentation termination judges:Mycelia dyeing is deep, and vacuole is more, and mycelia has fracture, autolysis.
Tank filtering is put, HZ818 is obtained, is soaked through conventional method, is detected, feldamycin HPLC normalization contents are 40% (see accompanying drawing 3).
Embodiment 3:Fermented and cultured prepares feldamycin
(1) fermented and cultured feldamycin
Preserving number is used for CCTCC NO:M 2017311 bacterial strain.
Shake-flask seed culture:0.5g containing glucose, cornstarch 0.5g, soy peptone 5g, ferment in per 100mL culture mediums Female powder 0.2g, beef extract 1.5g, soybean cake powder 1g, CaCO30.1g, remaining is water, and pH is natural.Access 5% (V/V's) 30% glycerine mycelia cryovial, 220rpm, 28 DEG C of cultures obtain seed liquor in 2 days.
Seed tank culture:0.5g containing glucose, dusty yeast 0.5g, cornstarch 1g, soybean protein in per 100mL culture mediums Peptone 5g, beef extract 1.5%, cotton seed meal 1g, corn starch 1g, KH2PO40.5g, CaCO30.1g, remaining is water, and pH is natural. Seed inoculum concentration 0.1% (V/V), 150rpm, 30 DEG C are cultivated 4 days.
Fermentation tank culture:1g containing glucose, maltodextrin 3g, dusty yeast 1g in per 100mL culture mediums, seitan powder 1g can Soluble starch 4g, KH2PO40.3g, FeSO4.7H2O 0.2g, potassium nitrate 0.5g, HZ818 3g, bubble enemy 0.1%, CaCO3 0.1g, remaining is water, and pH is natural.Seed inoculum concentration 5% (V/V), 180rpm, 30 DEG C are cultivated 9 days.
Tank filtering is put, HZ818 is obtained, is soaked through conventional method, is detected, feldamycin HPLC normalization contents are 42% (see accompanying drawing 4).
Embodiment 4:Fermented and cultured prepares feldamycin
(1) fermented and cultured feldamycin
Deposit number is used for CCTCC NO:M 2017311 bacterial strain
Shake-flask seed culture:1g containing sucrose, soluble starch 2g, soy peptone 0.5g, beef in per 100mL culture mediums Medicinal extract 0.5g, malt leaches powder 2g, soybean cake powder 1g, CaCO30.2g, remaining is water, pH6.8.Access the 30% of 3% (V/V) Glycerine mycelia cryovial, 250rpm, 28 DEG C, culture obtains seed liquor in 3 days.
Seed tank culture:1g containing sucrose, soluble starch 2g, soy peptone 1g, beef extract in per 100mL culture mediums 1g, malt leaches powder 2g, soybean cake powder 2g, CaCO30.2g, adds water to 500L, pH6.8.Seed inoculum concentration 0.2% (V/V), 180rpm, is cultivated 4 days by 26 DEG C.
Fermentation tank culture:It is beautiful per 100mL culture medium 2g containing glucose, maltodextrin 1g, dusty yeast 1g, cotton seed meal 0.5g Rice starch 2g, K2HPO40.3g, FeSO4.7H2O 0.2g, urea 0.2g, sodium nitrate 0.5g, CaCO30.4g, HB60 4g, bubble enemy 0.15%, remaining is water, pH6.8.Seed inoculum concentration 8% (V/V), 150rpm, 26 DEG C are cultivated 10 days.
Put tank filtering, obtain HB60, soaked through conventional method, detect, feldamycin HPLC normalization content be 43% (see Accompanying drawing 5).
Embodiment 5:Fermented and cultured prepares feldamycin
(1) fermented and cultured feldamycin
Deposit number is used for CCTCC NO:M 2017311 bacterial strain
Shake-flask seed culture:1.5g containing glucose, corn dextrin 3g, soy peptone 3g, soya bean in per 100mL culture mediums Cake powder 2g, yeast extract 2g, CaCO30.3g, remaining is water, and pH is natural.5% (V/V) 30% glycerine mycelia cryovial is accessed, 240rpm, 30 DEG C of cultures obtain seed liquor in 2 days.
Seed tank culture:2.0g containing glucose, cornstarch 4g, dusty yeast 2g, corn protein powder in per 100mL culture mediums 3g, soybean cake powder 2g, yeast extract 1g, CaCO30.3g, remaining is water, and pH is natural.Seed inoculum concentration 0.1% (V/V), 200rpm, 28 DEG C are cultivated 3 days.
Fermentation tank culture:0.5g containing glycerine, maltodextrin 4g, dusty yeast 1g, corn protein powder in per 100mL culture mediums 3g, KH2PO40.5g, sodium nitrate 1g, MgSO4.7H2O 0.2g, MnSO4.7H2O 0.1g, PAD900 5g, bubble enemy 0.2%, CaCO30.3g, remaining is water, pH7.0.Seed inoculum concentration 15% (V/V), 200rpm, 30 DEG C are cultivated 9 days.
Tank filtering is put, PAD900 is obtained, is soaked through conventional method, is detected, feldamycin HPLC normalization contents are 41% (see accompanying drawing 6).

Claims (7)

1. a kind of dactylosporangium aurantiacum (Dactylosporangium aurantiacum) FID1307, by Chinese Typical Representative culture Collection preservation, preserving number is CCTCC NO:M 2017311, preservation date is:On June 7th, 2017.
2. preserving number as claimed in claim 1 is CCTCC NO:M 2017311 bacterial strain is in fermentation prepares feldamycin Using.
3. the preserving number as described in application claim 1 is CCTCC NO:M 2017311 strain fermentation is prepared in feldamycin Method, it is characterised in that comprise the following steps:
A. fermentation strain uses deposit number for CCTCC NO:M 2017311 bacterial strain;
B. by the 30% glycerine mycelia cryovial prepared according to a conventional method, by 3~5% inoculation of shake-flask seed culture medium volume Amount access shake-flask seed culture medium, 220~260rpm cultivates 2~3 days, obtains shake-flask seed liquid;
The inoculum concentration that shake-flask seed liquid is accumulated into 0.1~0.2% by seed tank culture matrix is inoculated in seeding tank, 120~200rpm, Culture 3~4 days, obtains tank seed liquor;
Tank seed liquor is inoculated in fermentation tank culture medium by the inoculum concentration of fermentation tank culture medium volume 5~15%, 150~ 200rpm, fermented and cultured 9~12 days collects the resin in zymotic fluid;
Wherein cultivation temperature is 26~30 DEG C.
4. fermentation preparation as claimed in claim 3, it is characterized in that:
The ratio of shake-flask seed culture medium each component in the medium is:In every 100mL culture mediums, 1~4.5g of carbon source, nitrogen source 4 ~7.7g, 0.1~0.4g of inorganic salts, remaining is water;
The ratio of seed tank culture base each component in the medium is:In every 100mL culture mediums, 1.5~6g of carbon source, nitrogen source 5~ 9g, 0.2~0.6g of inorganic salts, remaining is water;
The ratio of fermentation tank culture medium each component in the medium is:In every 100mL culture mediums, 4.5~10g of carbon source, nitrogen source 1.7 ~5g, 0.8~1.8g of inorganic salts, 3~6g of resin, remaining is water.
5. fermentation preparation as claimed in claim 4, culture medium each component being preferably in a proportion of in the medium:
The ratio of shake-flask seed culture medium each component in the medium is:In every 100mL culture mediums, 2~3g of carbon source, nitrogen source 5~ 7g, 0.2~0.3g of inorganic salts, remaining is water;
The ratio of seed tank culture base each component in the medium is:In every 100mL culture mediums, 2~4g of carbon source, 6~8g of nitrogen source, 0.3~0.5g of inorganic salts, remaining is water;
The ratio of fermentation tank culture medium each component in the medium is:In every 100mL culture mediums, 5~8g of carbon source, 2~4g of nitrogen source, 0.8~1.2g of inorganic salts, 4~5g of resin, remaining is water.
6. the preparation method as described in claim 4 or 5, wherein described culture medium each group is divided into:Carbon source is selected from sucrose, grape Sugar, oatmeal, D- xyloses, D-ribose, galactolipin, maltose, maltodextrin, cornstarch, soluble starch, potato are formed sediment One or more in powder, corn dextrin, glycerine;Nitrogen source is selected from acid hydrolyzed casein, beef extract, yeast extract, yeast and leached Powder, malt leach powder, dusty yeast, soy peptone, peptone, seitan powder, cotton seed meal, soybean cake powder, corn starch, corn egg One or more in white powder, urea;Inorganic salts are selected from citrate, potassium nitrate, CaCO3、K2HPO4、MnSO4.7H2O、NaCl、 MgSO4.7H2O、FeSO4.7H2O、KH2PO4In one or more;The one kind of resin in HZ818, PAD900, HB60.
7. preparation method as claimed in claim 6, wherein described culture medium is preferably:Carbon source is glucose, cornstarch In one or more;Nitrogen source is beef extract, dusty yeast, soybean cake powder, soy peptone, corn protein powder, cotton seed meal It is one or more of;Inorganic salts are K2HPO4、KH2PO4、CaCO3One or more;Resin is HZ818 or PAD900.
CN201710473850.7A 2017-06-21 2017-06-21 A kind of dactylosporangium aurantiacum and its application in regulating microorganism metabolism object feldamycin Active CN107236686B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710473850.7A CN107236686B (en) 2017-06-21 2017-06-21 A kind of dactylosporangium aurantiacum and its application in regulating microorganism metabolism object feldamycin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710473850.7A CN107236686B (en) 2017-06-21 2017-06-21 A kind of dactylosporangium aurantiacum and its application in regulating microorganism metabolism object feldamycin

Publications (2)

Publication Number Publication Date
CN107236686A true CN107236686A (en) 2017-10-10
CN107236686B CN107236686B (en) 2019-10-15

Family

ID=59986570

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710473850.7A Active CN107236686B (en) 2017-06-21 2017-06-21 A kind of dactylosporangium aurantiacum and its application in regulating microorganism metabolism object feldamycin

Country Status (1)

Country Link
CN (1) CN107236686B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112111413A (en) * 2020-09-27 2020-12-22 贵州省生物技术研究所(贵州省生物技术重点实验室、贵州省马铃薯研究所、贵州省食品加工研究所) Trichoderma fermentation medium for antagonizing tea anthracnose pathogen and fermentation method

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004014295A2 (en) * 2002-07-29 2004-02-19 Optimer Pharmaceuticals, Inc. Tiacumicin production
CN102030791B (en) * 2010-10-28 2013-01-23 中国科学院南海海洋研究所 Four tiacumicin compounds as well as preparation methods and applications thereof in preparing antimicrobial agents
CN102115757B (en) * 2010-12-14 2015-10-28 中国科学院南海海洋研究所 Platform hooks biological synthesis gene cluster and the application thereof of mycin
CN102993251B (en) * 2012-12-17 2016-03-16 苏州纳微科技有限公司 A kind of method of high-efficient liquid phase chromatogram purification TCM B
CN103320355B (en) * 2013-05-29 2014-09-24 华北制药集团新药研究开发有限责任公司 Actinoplanessp. strain and its use in preparation of fidaxomicin
CN104846044B (en) * 2014-02-17 2019-02-01 上海医药工业研究院 A kind of fermentation medium improving feldamycin yield
CN104946708B (en) * 2014-03-28 2018-06-12 上海医药工业研究院 A kind of fermentation medium and fermentation process for producing feldamycin

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112111413A (en) * 2020-09-27 2020-12-22 贵州省生物技术研究所(贵州省生物技术重点实验室、贵州省马铃薯研究所、贵州省食品加工研究所) Trichoderma fermentation medium for antagonizing tea anthracnose pathogen and fermentation method
CN112111413B (en) * 2020-09-27 2023-08-08 贵州省生物技术研究所(贵州省生物技术重点实验室、贵州省马铃薯研究所、贵州省食品加工研究所) Trichoderma fermentation medium for antagonizing tea anthracnose pathogen and fermentation method

Also Published As

Publication number Publication date
CN107236686B (en) 2019-10-15

Similar Documents

Publication Publication Date Title
CN101899410B (en) Streptomyces parvus and application thereof for preparing daptomycin
CN102161975B (en) Streptomyces sp. GSDX-1318, and fermentation method for producing oligosaccharide antibiotic avilamycin
CN104560827B (en) A kind of biocontrol actinomycetes bacterial strain for preventing and treating tobacco bacterial wilt and its application
CN108676757A (en) One streptomycete category bacterial strain and its application for producing staurosporine
CN104087511A (en) Mucor racemosus strain and its application
CN106497806A (en) A kind of coronoid process dissipate capsule bacterium strain and its application
CN101245362B (en) Method for producing polypeptide antibiotic enramycin by fermentation method
CN103087928B (en) Fungus Glarea lozoyensis and application thereof for controlling microbial metabolite Pneumocandin Kangding B0
CN101089175A (en) Aspergillus niger WZ001 capable of producing naringinase and cirmtimase simultaneously and its application
CN103146624A (en) Mixed liquid fermentation process of three plants of bacillus licheniformis
CN106148216B (en) A kind of streptomycete and its method for producing mibemycin A3
CN110157623A (en) A kind of method of reaping hook bacteria strain and its fermenting and producing D-pantoyl lactone hydrolase
CN102766592A (en) Bacillus amyloliquefaciens and application thereof
CN105838645A (en) Actinoplanes utahensis and application thereof in preparing acarbose
CN109182147A (en) A kind of mould and its method for producing fumidil
CN104560766B (en) A kind of Actinoplanes bacteria strain and its application
CN108823110B (en) Strain for producing griseofulvin and application thereof
CN108841889B (en) Method for producing griseofulvin serving as major component of tranexamycin by microbial fermentation
CN102417890B (en) Sinorhizobium meliloti and method for applying same for fermenting to produce manganese peroxidase
CN103374537B (en) Method for preparing enduracidin and strain produced thereby
CN110317734A (en) A kind of monascus and its isolated culture method and the application of high-yield glucoamylase, Esterified Enzyme and protease
CN102127515B (en) Screening and application of L-proline high-producing Brevundimonas sp. (JNPP-1)
CN104450571B (en) A kind of bacillus thuringiensis bacterial strain of efficient degradation fly-maggot protein
CN102796680B (en) A kind of Streptomyces roseosporus and its method for producing Daptomycin using precursor is combined
CN110713956B (en) Lysine bacillus S12 and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
EE01 Entry into force of recordation of patent licensing contract
EE01 Entry into force of recordation of patent licensing contract

Application publication date: 20171010

Assignee: Hangzhou Huadi Pharmaceutical Technology Co.,Ltd.

Assignor: Hangzhou Huadong Medicine Group Biopharmaceutical Co.,Ltd.

Contract record no.: X2021330000100

Denomination of invention: An orange finger sporangium and its application in regulating microbial metabolite fidamycin

Granted publication date: 20191015

License type: Common License

Record date: 20210820